HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ethylcholine aziridinium

causes passive avoidance deficits
Also Known As:
1-ethyl-1-(2-hydroxyethyl)aziridinium chloride; AF64A; AF64A-picrylsulfonate; ethylcholine aziridinium chloride; ethylcholine aziridinium, 2,4,6-trinitrobenzenesulfonic acid salt (1:1); ethylcholine mustard aziridinium
Networked: 46 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Wattanathorn, Jintanaporn: 2 articles (07/2011 - 01/2010)
2. Bae, Dae-Kwon: 1 article (04/2012)
3. Matsuo, Akinori: 1 article (04/2012)
4. Kim, Yun-Bae: 1 article (04/2012)
5. Tooyama, Ikuo: 1 article (04/2012)
6. Lee, Hong Jun: 1 article (04/2012)
7. Yang, Goeun: 1 article (04/2012)
8. Lim, Inja: 1 article (04/2012)
9. Kim, Seung U: 1 article (04/2012)
10. Yang, Yun-Hui: 1 article (04/2012)

Related Diseases

1. Seizures (Seizure)
2. Neuroblastoma
3. Glioma (Gliomas)
4. Alzheimer Disease (Alzheimer's Disease)
5. Memory Disorders (Memory Loss)

Related Drugs and Biologics

1. ethylcholine aziridinium
2. Choline O-Acetyltransferase (Choline Acetyltransferase)
3. Choline (Choline Chloride)
4. Scopolamine (Hyoscine)
5. Excitatory Amino Acid Antagonists
6. Cholinergic Agents (Cholinergics)
7. 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
8. Vincristine (Oncovin)
9. Tacrine (Cognex)
10. Sodium

Related Therapies and Procedures

1. Catheters
2. Intraocular Injections
3. Injections
4. Denervation